Edwin Rock

All filings by Edwin Rock on record concern Crescent Biopharma, Inc. In total, 4 filings cover trades dated from 14 November 2022 to 20 June 2024.

Purchases make up the whole of the open-market record (4 purchases, €462k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2024, the count stands at 1 purchase and no sales.

In size, the median ticket on the buying side is €92k. 2 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 24 June 2024: an open-market purchase of €45k, in Crescent Biopharma, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.